Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial-Reference-Cited by-同舟云学术

Dexpramipexole versus placebo for patients with amyotrophic lateral sclerosis (EMPOWER): a randomised, double-blind, phase 3 trial

Published:2013-11 Issue:11 Volume:12 Page:1059-1067
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Cudkowicz Merit E,van den Berg Leonard H,Shefner Jeremy M,Mitsumoto Hiroshi,Mora Jesus S,Ludolph Albert,Hardiman Orla,Bozik Michael E,Ingersoll Evan W,Archibald Donald,Meyers Adam L,Dong Yingwen,Farwell Wildon R,Kerr Douglas A

Publisher

Elsevier BV

Subject

Clinical Neurology

Reference35 articles.

1. Amyotrophic lateral sclerosis;Rowland;N Engl J Med,2001

2. Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies;Bruijn;Expert Rev Neurother,2006

3. Amyotrophic lateral sclerosis: from current developments in the laboratory to clinical implications;Cozzolino;Antioxid Redox Signal,2008

4. Current and prospective disease-modifying therapies for amyotrophic lateral sclerosis;Morren;Expert Opin Investig Drugs,2012

5. A controlled trial of riluzole in amyotrophic lateral sclerosis;Bensimon;N Engl J Med,1994

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revisiting Glutamate Excitotoxicity in Amyotrophic Lateral Sclerosis and Age-Related Neurodegeneration;International Journal of Molecular Sciences;2024-05-21

2. Rare and common genetic determinants of mitochondrial function determine severity but not risk of amyotrophic lateral sclerosis;Heliyon;2024-02

3. Integrating Transcriptomic and Structural Insights: Revealing Drug Repurposing Opportunities for Sporadic ALS;ACS Omega;2024-01-10

4. Animal Models of FUS-Proteinopathy: A Systematic Review;Biochemistry (Moscow);2024-01

5. Refashioning dexpramipexole: A new horizon in eosinophilic asthma?;Journal of Allergy and Clinical Immunology;2023-11